Subcutaneous omalizumab + steroid vs placebo + steroid (stable steroid)
Exacerbations (number of people experiencing ≥ 1 exacerbations) · people with asthma
Subcutaneous omalizumab + steroid probably leads to lower number of participants with at least one exacerbation Moderate to… compared with placebo + steroid (stable steroid) (moderate certainty).
1 finding from 1 review
- OR 0.5 [0.42, 0.6]7 studies · 2889 participantsModerate